Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

NCT03016741 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Castration-Resistant Prostatic Cancer
Metastatic Prostate Carcinoma
Recurrent Prostate Carcinoma
Stage IV Prostate Cancer
Hormone-Refractory Prostate Cancer

Interventions

BIOLOGICAL: GnRH agonist/antagonist
DRUG: Prednisone
DRUG: Abiraterone Acetate
DRUG: Enzalutamide

Sponsor

Northwestern University